Eventide Asset Management’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
2017
Q2
$2.33M Hold
2017
Q1
$2.59M Hold
2016
Q4
$1.65M Hold
2016
Q3
$2.35M Hold
2016
Q2
$1.53M Hold
2016
Q1
$1.94M Buy
2015
Q4
$2.09M Buy